EdgarLookup

Jasper Therapeutics, Inc. — All Filings

431 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 25-NSE 3 3/A 4 424B3 424B4 424B5 425 8-A12B 8-K 8-K/A ARS CERT CORRESP DEF 14A DEFA14A DRS EFFECT NT 10-Q POS AM PRE 14A S-1 S-1/A S-3 S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
UPLOAD 0000000000-25-003070 Mar 21, 2025
S-3 REGISTRATION STATEMENT 0001213900-25-025077 Mar 19, 2025
8-K CURRENT REPORT 0001213900-25-025123 Mar 19, 2025 Mar 14, 2025
10-K ANNUAL REPORT 0001213900-25-018384 Feb 28, 2025 Dec 31, 2024
8-K CURRENT REPORT 0001213900-25-017656 Feb 27, 2025
4 0001213900-25-014951 Feb 18, 2025 Feb 13, 2025
4 0001213900-25-014950 Feb 18, 2025 Feb 13, 2025
4 0001213900-25-014948 Feb 18, 2025 Feb 13, 2025
4 0001213900-25-014949 Feb 18, 2025 Feb 13, 2025
SCHEDULE 13G/A 0001213900-25-012186 Feb 11, 2025
8-K CURRENT REPORT 0001213900-25-001810 Jan 8, 2025
144 0001213900-24-108550 Dec 12, 2024
4 0001213900-24-108551 Dec 12, 2024
SC 13G/A 0000919574-24-006774 Nov 14, 2024
SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-24-098328 Nov 14, 2024
SC 13G 0002012383-24-003556 Nov 8, 2024
10-Q QUARTERLY REPORT 0001213900-24-095173 Nov 7, 2024 Sep 30, 2024
8-K CURRENT REPORT 0001213900-24-095175 Nov 7, 2024
SC 13G/A SC 13G/A 0001178913-24-003454 Nov 4, 2024
SC 13G 0002012383-24-001610 Oct 22, 2024
8-K CURRENT REPORT 0001213900-24-087394 Oct 15, 2024 Oct 14, 2024
144 0001213900-24-078213 Sep 12, 2024
4 0001213900-24-078214 Sep 12, 2024
10-Q QUARTERLY REPORT 0001213900-24-067897 Aug 13, 2024 Jun 30, 2024
3 0001213900-24-053987 Jun 20, 2024 Jun 18, 2024
4 0001213900-24-053989 Jun 20, 2024 Jun 18, 2024
8-K CURRENT REPORT 0001213900-24-053982 Jun 20, 2024 Jun 17, 2024
4 0001213900-24-052215 Jun 12, 2024
8-K CURRENT REPORT 0001213900-24-051891 Jun 12, 2024 Jun 6, 2024
4 0001213900-24-052087 Jun 12, 2024 Jun 10, 2024
144 0001213900-24-052213 Jun 12, 2024
4 0001213900-24-051417 Jun 10, 2024 Jun 7, 2024
4 0001213900-24-051414 Jun 10, 2024 Jun 6, 2024
4 0001213900-24-051398 Jun 10, 2024 Jun 6, 2024
4 0001213900-24-051405 Jun 10, 2024 Jun 6, 2024
4 0001213900-24-051401 Jun 10, 2024 Jun 6, 2024
4 0001213900-24-051411 Jun 10, 2024 Jun 6, 2024
4 0001213900-24-051409 Jun 10, 2024 Jun 6, 2024
4 0001213900-24-051416 Jun 10, 2024 Jun 6, 2024
S-8 POS POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 0001213900-24-050843 Jun 7, 2024
S-8 POS POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 0001213900-24-050849 Jun 7, 2024
S-8 POS POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 0001213900-24-050838 Jun 7, 2024
S-8 REGISTRATION STATEMENT 0001213900-24-050751 Jun 7, 2024
10-Q QUARTERLY REPORT 0001213900-24-042805 May 14, 2024 Mar 31, 2024
DEFA14A ADDITIONAL MATERIALS 0001213900-24-039304 May 3, 2024
ARS FORM ARS 0001213900-24-034840 Apr 22, 2024 Dec 31, 2023
DEF 14A PROXY STATEMENT 0001213900-24-034820 Apr 22, 2024 Jun 6, 2024
DEFA14A ADDITIONAL MATERIALS 0001213900-24-034831 Apr 22, 2024
SC 13G 0000919574-24-002193 Mar 27, 2024
144 0001213900-24-021952 Mar 12, 2024